Lingraphicare America, Inc. 103 Carnegie Ctr Ste 104

Form 483 issued November 15, 2019 · Princeton, New Jersey

Inspection
Nov 5 – Nov 15, 2019
Observations
1
Pages
8
FEI number
1000123978

In short: On November 15, 2019, FDA issued a Form 483 with 1 observation to Lingraphicare America, Inc. 103 Carnegie Ctr Ste 104 in Princeton, New Jersey (FEI 1000123978) after an inspection that ran Nov 5 – Nov 15, 2019. The investigators were Gobiga Vanniyasingam and Michelle L. Johnson. Most observations concern cAPA; the most-cited regulation is 21 CFR 820.198 (complaint files).

At a glance

1 of 1 observations on this 483 concern capa.

CAPA1

Most cited: 21 CFR 820.198(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lingraphicare America, Inc. 103 Carnegie Ctr Ste 104?

FDA listed 1 observation on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 820.198 (complaint files). The opening words of each observation are shown on this page.

Who inspected Lingraphicare America, Inc. 103 Carnegie Ctr Ste 104?

Gobiga Vanniyasingam and Michelle L. Johnson are named on this Form 483, for the inspection of Nov 5 – Nov 15, 2019. Each investigator has a profile showing what they cite most.

When was Lingraphicare America, Inc. 103 Carnegie Ctr Ste 104 inspected by FDA?

The inspection ran Nov 5 – Nov 15, 2019, and the Form 483 is dated November 15, 2019.

How do I get the full Form 483 for Lingraphicare America, Inc. 103 Carnegie Ctr Ste 104?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free